申请人:Dyer Dennis Richard
公开号:US20060040957A1
公开(公告)日:2006-02-23
Selective MMP-13 inhibitors are bicyclic pyrimidines of the Formula I
or a pharmaceutically acceptable salt thereof, wherein R
1
is hydrogen or alkyl; R
2
, R
3
, and R
4
include hydrogen, halo, alkyl, C≡C(CH
2
)
m
aryl, CO
2
alkyl, CO
2
(CH
2
)
m
aryl, COHN alkyl, and CONH(CH
2
)
m
aryl; and X is O, S, SO, SO
2
, CH
2
, C═O, CHOH, NH, or NR
5
.
A compound of Formula I, or a pharmaceutically acceptable salt thereof, is useful for treating cancer or arthritis.
选择性
MMP-13
抑制剂是公式I的双环
嘧啶或其药学上可接受的盐,其中R1为
氢或烷基;R2,R3和R4包括
氢,卤素,烷基,C≡C(
CH2)芳基,
CO2烷基, ( )芳基,COHN烷基和CONH( )芳基;X为O,S,SO,SO2, ,C═O,CHOH,NH或NR5。公式I的化合物或其药学上可接受的盐,可用于治疗癌症或关节炎。